Prevalence and Risk Factors for Pain and Related Adverse Reactions Among Breast Cancer Survivors on Aromatase Inhibitors

Clinical trial NCT05628077 · UNKNOWN

Trial details

NCT number: NCT05628077
Sponsor: Peking University People's Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Breast Cancer Aromatase Inhibitors Endocrine Therapy Pain Anxiety Depression Sleep

Start date: 2022-12-30
Primary completion: 2023-03-20
Enrollment: 1200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.